Popular Articles
Natural Remedies

Interventional Radiology For Treating Conditions Specific To Women
Interventional radiology is a dynamic and innovative specialty. In the last ten years new image guided therapies for uterine myomata, infertility, pelvic pain, osteoporosis, and varicose veins have largely been developed. Interventional Radiology in Women"s Health, published by Thieme, focuses on women"s health and the expanding role of interventional radiology within this pioneering area of medicine.
generic viagra online
Denver Post Examines Efforts To Establish Needle-Exchange Programs In Colorado
The Denver Post on Friday examined efforts to establish needle-exchange programs in Colorado to reduce the risk of HIV and hepatitis C among injection drug users. According to the Post, 185 cities in Colorado have needle-exchange programs, but legislation that would have legalized needle exchanges statewide did not advance in the Legislature this year. "The issue is more complex than it perhaps first appears," Evan Dreyer, a spokesperson for Gov. Bill Ritter (D), said, adding that "law enforcement and the Colorado Department of Public Health and Environment both expressed serious reservations" about a proposal that would have legalized needle-exchanges statewide. A coalition of public health officials, treatment providers and advocates are increasing efforts to establish a needle-exchange program in Denver, the Post reports. The Denver Drug Strategy Commission in February recommended that Mayor John Hickenlooper consider a pilot needle-exchange program, DDSC Director Karla Maraccini said. The commission is looking at different programs to develop a model following Hickenlooper"s request for additional research. However, Denver District Attorney Mitch Morrissey has concerns that a local needle-exchange program would violate state law, according to Morrissey"s spokesperson Lynn Kimbrough. Eric Brown, a spokesperson for Hickenlooper, added, "Anything in contradiction to city or state law would have to be carefully considered." Proponents of needle-exchange programs say they prevent HIV and hepatitis C, but opponents say they condone injection drug use. Mark Thrun, director of HIV prevention for Denver Public Health, said, adding that needle-exchange programs prevent IDUs from "getting these chronic, potentially fatal diseases" and give public health workers "an opportunity to link them into treatment; and it lessens the economic burden on the already overburdened health care system." Thrun noted that several studies have found that needle-exchange programs do not encourage or prolong injection drug use and make IDUs more likely to seek treatment. In addition, a 2005 CDC study found that 86% of exchange programs make treatment referrals and that more than 80% offer counseling and testing for HIV/AIDS and hepatitis C.Nancy Steinfurth, executive director of the Hep C Connection, noted that an estimated 10% of HIV cases and 70% of hepatitis C cases are transmitted through needles (Auge, Denver Post, 5/15).
News of the day
Perceived Cancer Risks May Not Reflect Actual Risks Or Prevention Needs
Working with a population of individuals at risk for gastrointestinal cancers, researchers at Fox Chase Cancer Center have learned that many people misjudge their actual degree of cancer risk and, therefore, their true need for prevention support. Strategies for accurately assessing cancer risk are critical for appropriately targeting educational, counseling, and diagnostic res to prevent cancer in as many individuals as possible, the investigators say.
Diagnostics

First Minister Announces Funding For Second Phase Of Life Sciences Institute, Wales

First Minister Rhodri Morgan announced (date) that almost ÷£30 million of funding has been secured for phase two of the Institute of Life Science at Swansea University, with the promise of up to 650 jobs. The Welsh Assembly Government is providing ÷£8.5 million towards the cost of the project, which will also receive ÷£12.8 million from the European Regional Development Convergence Fund, ÷£6.4 million from Swansea University and ÷£1 million from Abertawe Bro Morgannwg University NHS Trust. Phase two of the Institute will include a clinical research centre and will also play a major role in developing new products and services for the healthcare industry. The first phase of the Institute, which opened in 2007, already boasts state-of-the-art laboratories researching areas such as cancer, obesity and diabetes. First Minister, Rhodri Morgan, said: "This massive announcement in the knowledge economy in Wales shows that we are not just seeking to survive this recession; we are also positioning Wales in the right place to be competitive in the upturn, when it comes." The Welsh Assembly Government is keen to facilitate and encourage collaboration between business and our world-class universities. With the second phase of the Institute of Life Science we can further develop and support the growing Life Science knowledge cluster in south west Wales, the UK and around the world." Deputy First Minister, Ieuan Wyn Jones, welcomed the announcement: "This is a major boost for the economy of south west Wales as well as a significant step forward for research and development. This new phase of the Institute will not only create new jobs in the region but it will also have the ability to support hundreds of businesses through technology and research." Health Minister, Edwina Hart, added: "This demonstrates the importance we place on medical research and the benefits it can deliver. The work at the Institute of Life Science complements the on-going studies and developments at the National Institute for Health and Social Care Research which was established earlier this year as part of the Welsh Assembly Government"s commitment to support and stimulate health and social care research to improve the health and well being of people in Wales." Vice-Chancellor for Swansea University, Professor Richard B. Davies, said: "This announcement is hugely significant for Swansea University. The recent UK Research Assessment Exercise showed the high quality of research in the vibrant Institute of Life Science. The new funding will allow the School of Medicine to build upon this success, increasing the scale of activity to create a globally competitive centre of excellence in life science research. The whole region and beyond will benefit from the resulting advances in medical practice and through the development of a cluster of high-technology life science companies." Acting Chief Executive of Abertawe Bro Morgannwg University NHS Trust, Calum Campbell, said: "The Trust is delighted with this announcement as it underlines the important role of research in pushing forward excellence in healthcare. The Trust and Swansea University have formed a close partnership which is built on this belief, and this second phase of the Institute of Life Science is very important." Welsh Assembly Government


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):